The Feinstein Institute for Medical Research - The North Shore-LIJ Health System
Mr Chad Bouton
Division Leader, Neurotechnology and Analytic - Managing Director, Center for Bioelectronic MedicineThe Feinstein Institute for Medical Research - The North Shore-LIJ Health System
Professor Christopher J. Czura
VP, Scientific Affairs - Executive Director, Merinoff Symposia - Publisher of Molecular Medicine and Bioelectronic MedicineThe Feinstein Institute for Medical Research - The North Shore-LIJ Health System
Ms Carol Ann Amella
Administrative Director of the Center for Bioelectronic Medicine
The MedTech Strategist
– Subscribers to The MedTech Strategist include device market leaders, start-ups, investors, management consulting firms, law firms, physician entrepreneurs, engineers, and scientists, among many others with a stake in the rapidly evolving device space

The New York Stem Cell Foundation
The New York Stem Cell Foundation (NYSCF) is a non-profit organization whose mission is to accelerate stem cell research to cure the major diseases of our time. Our programs are focused in three areas:
• Directing critical, advanced stem cell research in its own laboratory and also supports advanced work in other leading institutions.
• Developing the next generation of top stem cell scientists by training and supporting an elite group of post-doctoral research fellows.
• Convening the preeminent annual translation stem cell research conference and an on-going series of programs for scientists, policymakers and the public.
Medical Research, Events, Research Funding

The Rare Genomics Institute
Rare Genomics Institute empowers patient communities to accelerate research by helping fund and create personalized research projects based on individuals with rare diseases. Their first initiative is to sequence the genomes of these patients. To do this, they provide three innovative services. First, a micro-funding website: an online fundraising platform and social network that helps patient communities raise funds. Second, a researcher network: access to top genomics researchers who are willing to sequence and analyze these patients. Third, a clinical network: connecting patients with clinicians and genetic counselors who will help interpret and translate the individualized research findings.
SpecialtiesGenomics, Rare Diseases, Next-Generation Sequencing, Crowdfunding

The Solution Lab
Affordable management consulting services to startups and larger orgs in life sciences and healthcare. Team based model powered by students and recent grads in STEM, healthcare/clinical, and business backgrounds who are interested in gaining high-intensity professional development opportunities in team based environments.

The Triana Group, Inc.
The Triana Group is a technology business development company based in the Wall Street area of Manhattan. We specialize in introducing new technologies to strategic partners and setting up go-to-market strategies such as collaborations, joint-ventures, and pitches to key accounts. We are currently advisers to, and part of the executive teams of several projects in the healthcare space, and occasionally consider joining as partners or shareholders. We have direct access to a number of hospitals, ACOs (Accountable Care Organizations), Insurers, as well as nationwide hospital GPOs totaling hundreds of billions of purchasing power (Grouped Purchasing Organizations).

Torreya Insights
Torreya Insights is a professional and data services company that integrates advice, transaction preparation and database analysis for life science companies. We primarily service business development and financing professionals in the biotech and pharmaceutical industries.
We are a sister company to Torreya Partners, a leading life sciences boutique M&A and financial advisory firm based in New York, which since its inception in 2007 has completed over 100 transactions in life sciences (www.torreyapartners.com). We work closely with Torreya Partners to seamlessly integrate the services that we provide to our clients.
Our engagements usually center around assisting companies in business development transactions, including capital raise, valuation, as well as locating suitable assets for acquisition or potential partners for further asset development.
We also provide access to AvaRx (which soft launched in January 2014) is a searchable dynamic database of over 2,000 licensing opportunities.
Follow us at @TorreyaInsights for updates.
Licensing / M&A Opportunity Identification, Research and Data Services, AvaRx – Licensing Opportunity Database, BioPharma CRM & Contact Solutions, Licensing Dynamics, Financing Dynamics